跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 471 条关于
“POLε”
全部
471
临床试验
389
药物
53
机构
7
资讯
22
2年前
Dostarlimab Shows Superior Survival Outcomes Across Multiple Endometrial Cancer Molecular Subgroups in Phase 3 RUBY Trial
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
2年前
Toripalimab Shows Promise in Advanced Solid Tumors with POLE/POLD1 Mutations
10个月前
Rare POLE Gene Mutation Predicts Strong Immunotherapy Response in Colorectal Cancer
2年前
Poolbeg Pharma's POLB 001 Shows Promise in Preventing Cancer Immunotherapy-Induced CRS
第 1 页,共 3 页
上一页
下一页